Celltrion plans to launch point-of-care antigen testing (POCT) kit in July in collaboration with BBB, a South Korean healthcare technology company that specialises in lab-on-a-chip technology ...
Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results